Back to results
US 2022/0023241 A1Published application
Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
AssigneeBoard of Regents, The University of Texas System
InventorsThomas J. SLAGA, Jacob JUNCO, Huiyun LIANG, Sara REYNA
Life of this patent
Estimating the term…
Abstract
Certain embodiments are directed to methods and compositions for treating obesity, diabetes, and/or cancer with a combination of ursolic acid and resveratrol.
Claims18
A method of decreasing inflammation in a human, the method comprising:
- consuming an effective amount of the nutritional supplement to decrease inflammation in the human, wherein the nutritional supplement is formulated to be consumed one or mores time per day;
- continuing the consuming for multiple days;
- and
- decreasing inflammation in the human;
- wherein the nutritional supplement comprises ursolic acid and resveratrol in a ratio of ursolic acid to resveratrol of 3:1 to 1:3,
- wherein the nutritional supplement is formulated for oral consumption as a tablet, a capsule, a concentrate, a powder, a drink, or a food, and
- wherein the nutritional supplement is consumed in addition to food in a normal diet.
4 more elements
Dependencies are inferred from the claim text.